BackAmphastar Pharmaceuticals Overview
Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Target Price

Where could AMPH trade next? Consensus target price: $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$22.96

Average Target Price

$20.759.6% downside

4 analysts in the last 4 months

High: $23 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-18Barclays$230.2% upsideOpen
2026-06-03Barclays$2012.9% downsideOpen
2026-05-14Wells FargoBenjamin Burnett$1917.2% downsideOpen
2026-05-11Piper Sandler$218.5% downsideOpen
2026-04-20JefferiesDennis Ding$224.2% downsideOpen
2025-12-08Barclays$3030.7% upsideOpen
2025-03-21Piper SandlerDavid Amsellem$3239.4% upsideOpen
2024-08-08Piper SandlerDavid Amsellem$66187.5% upsideOpen
2024-05-23Piper SandlerDavid Amsellem$71209.2% upsideOpen
2022-03-12Piper SandlerDavid Amsellem$3552.4% upsideOpen

Amphastar Pharmaceuticals (AMPH) FAQ

The latest target price for AMPH is $21. Investors often review this figure alongside Amphastar Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Amphastar Pharmaceuticals trades near $22.96 while the consensus target sits at $21 (9.6% downside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting AMPH's target price ($21), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Amphastar Pharmaceuticals's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.